Pharmacotherapy for obesity: What you need to know

被引：28

作者：

Bersoux, Sophie ^{[1
]}

Byun, Tina H. ^{[1
]}

Chaliki, Swarna S. ^{[1
]}

Poole, Kenneth G., Jr. ^{[1
]}

机构：

[1] Mayo Clin, Med, Coll Med & Sci, Div Community Internal Med, Scottsdale, AZ USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2017年 / 84卷 / 12期

关键词：

CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; WEIGHT-LOSS; RANDOMIZED-TRIAL; PRIMARY-CARE; PHARMACOLOGICAL-TREATMENT; PRACTICE GUIDELINES; OVERWEIGHT ADULTS; BLOOD-PRESSURE; RISK-FACTORS; LORCASERIN;

D O I：

10.3949/ccjm.84a.16094

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Weight-loss drugs are being evaluated for their role in obesity management. This article reviews the available weight-loss drugs, their efficacy and side effects, and their best clinical use.

引用

页码：951 / 958

页数：8

共 48 条

[1] Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) [J].

Allison, David B. ;

Gadde, Kishore M. ;

Garvey, William Timothy ;

Peterson, Craig A. ;

Schwiers, Michael L. ;

Najarian, Thomas ;

Tam, Peter Y. ;

Troupin, Barbara ;

Day, Wesley W. .

OBESITY, 2012, 20 (02) :330-342

[2]

American Association of Clinical Endocrinologists, AACE ACE ALG MED CAR

[3]

[Anonymous], OV OB STAT

[4]

[Anonymous], 2017, OR THER

[5] A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II) [J].

Apovian, Caroline M. ;

Aronne, Louis ;

Rubino, Domenica ;

Still, Christopher ;

Wyatt, Holly ;

Burns, Colleen ;

Kim, Dennis ;

Dunayevich, Eduardo .

OBESITY, 2013, 21 (05) :935-943

[6] Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide [J].

Astrup, A. ;

Carraro, R. ;

Finer, N. ;

Harper, A. ;

Kunesova, M. ;

Lean, M. E. J. ;

Niskanen, L. ;

Rasmussen, M. F. ;

Rissanen, A. ;

Rossner, S. ;

Savolainen, M. J. ;

Van Gaal, L. .

INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (06) :843-854

[7] Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs [J].

Chan, E. W. ;

He, Y. ;

Chui, C. S. L. ;

Wong, A. Y. S. ;

Lau, W. C. Y. ;

Wong, I. C. K. .

OBESITY REVIEWS, 2013, 14 (05) :383-392

[8] Valvular heart disease associated with fenfluramine-phentermine [J].

Connolly, HM ;

Crary, JL ;

McGoon, MD ;

Hensrud, DD ;

Edwards, BS ;

Edwards, WD ;

Schaff, HV .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588

[9]

Drug Enforcement Administration, 2013, FED REGISTER, V78, P26701

[10] A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial [J].

Fidler, Meredith C. ;

Sanchez, Matilde ;

Raether, Brian ;

Weissman, Neil J. ;

Smith, Steven R. ;

Shanahan, William R. ;

Anderson, Christen M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10) :3067-3077

← 1 2 3 4 5 →